As of 2025-04-18, the Relative Valuation of Bioharvest Sciences Inc (BHSC.CN) is (4.78) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 7.95 CAD, the upside of Bioharvest Sciences Inc based on Relative Valuation is -160.1%.
The range of the Relative Valuation is (4.40) - (4.54) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.2x - 3.3x | 3.2x |
| Forward P/E multiples | 3.1x - 4.3x | 3.7x |
| Fair Price | (4.40) - (4.54) | (4.78) |
| Upside | -155.4% - -157.1% | -160.1% |
| Date | P/E |
| 2025-02-14 | -8.01 |
| 2025-02-13 | -8.01 |
| 2025-02-10 | -8.57 |
| 2025-02-07 | -8.17 |
| 2025-02-06 | -8.06 |
| 2025-02-05 | -8.06 |
| 2025-02-03 | -7.16 |
| 2025-01-31 | -7.11 |
| 2025-01-29 | -7.27 |
| 2025-01-28 | -7.40 |
| 2025-01-27 | -7.74 |
| 2025-01-24 | -7.81 |
| 2025-01-23 | -7.71 |
| 2025-01-22 | -8.06 |
| 2025-01-21 | -8.35 |
| 2025-01-20 | -8.32 |
| 2025-01-17 | -8.32 |
| 2025-01-16 | -8.57 |